Inducement Grant Under Nasdaq Listing
-
Financial
InVivo Therapeutics Announces Richard Christopher as CFO and Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
January 14, 2019 CAMBRIDGE, Mass.–(BUSINESS WIRE)–InVivo Therapeutics Holdings Corp. (Nasdaq:NVIV), a research and clinical-stage biomaterials and biotechnology company with a focus…
Read More »